Clinical trial
Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of…
NCT00120198 · Geriatric Oncology Consortium, Other · Terminated
Key facts
| NCT number | NCT00120198 |
|---|---|
| Title | Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients |
| Official title | A Pilot Study of Cyclophosphamide/Pegylated Liposomal Doxorubicin/Vincristine/Prednisone (CDOP) Plus Rituximab for Treatment of Elderly Patients With Previously Untreated Non-Hodgkin's Lymphoma |
| Lead sponsor | Geriatric Oncology Consortium, Other |
| Collaborators | Tibotec Pharmaceutical Limited Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | CDOP plus rituximab |
| Enrollment | 50 |
| Start date | Mar 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Jul 15, 2005 |
| Last update posted | Nov 16, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: